Imaging modalities in synchronous oligometastatic prostate cancer
Sign Up to like & getrecommendations! Published in 2018 at "World Journal of Urology"
DOI: 10.1007/s00345-018-2416-2
Abstract: PurposeAlong with a number of other malignancies, the term “oligometastatic” prostate cancer has recently emerged. It represents an attempt to define a subtype of cancer with a limited metastatic load that might perform more favorably… read more here.
Keywords: oligometastatic prostate; imaging modalities; prostate cancer; cancer ... See more keywords
Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
Sign Up to like & getrecommendations! Published in 2019 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2019.03.005
Abstract: Purpose We examined long-term clinical outcomes among patients with synchronous oligometastatic non-small cell lung cancer (NSCLC) treated at our institution with definitive thoracic chemoradiation therapy (CRT) and local therapy to all oligometastatic lesions. Methods and… read more here.
Keywords: institution; long term; therapy; progression ... See more keywords
High-dose planned adaptive intensity-modulated radiation therapy with simultaneous integrated boost for synchronous oligometastatic pancreatic cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Cancer investigation"
DOI: 10.1080/07357907.2022.2049287
Abstract: The purpose of this study was to investigate the efficacy and feasibility of high-dose (72.6 Gy) planned adaptive intensity modulated radiation therapy (IMRT) with simultaneous integrated boost (SIB) for 9 consecutive patients with synchronous oligometastatic pancreatic… read more here.
Keywords: intensity modulated; adaptive intensity; synchronous oligometastatic; planned adaptive ... See more keywords
Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2017.02.21
Abstract: BACKGROUND We performed a meta-analysis to compare overall survival (OS) outcomes in patients with synchronous oligometastatic non-small cell lung cancer (NSCLC) who underwent aggressive thoracic therapy (ATT) with those who did not. METHODS A systematic… read more here.
Keywords: patients synchronous; thoracic; oligometastatic non; synchronous oligometastatic ... See more keywords